Développement d'un dispositif de traçabilité pour Pfizer Canada

辉瑞加拿大公司是一家于2004年4月注册成立的加拿大公司，生产和销售医药产品。为了在药物和疫苗的开发和制造方面实现增长和创新，辉瑞加拿大公司希望开发一种系统，用于跟踪从生产线到销售柜台上提供的产品的药瓶。这一发展需要开发一种高容量、已编程的RFID 4.0标签设备，适用于1cm x 2cm的小玻璃瓶（每年约10，000，000种产品），每个标签的成本低于0.15美元，带有固定的双天线RFID阅读器，用于检测库存条目和拒绝，每个阅读器的成本低于5，000美元。该系统可以控制和确保疫苗瓶从生产到分销的个人可追溯性，还必须将收集的数据集成到公司的专有软件平台中。为此，辉瑞加拿大公司正在寻求C2T3在无线电信和RFID方面的专业知识，以确定开发这种创新设备的可能解决方案。对于辉瑞加拿大公司来说，该项目是一个重要的创新工具，可以根据FDA、加拿大卫生部和工业4.0标准为该业务线制定公司的最佳实践。

Pfizer Canada Inc. is a Canadian company incorporated in April 2004 that manufactures and markets pharmaceutical products. In order to grow and innovate in the development and manufacture of drugs and vaccines, Pfizer Canada wants to develop a system for tracking pharmaceutical vials from the manufacturing lines to the products available on the sales counters. This development requires the development of a high-capacity, already programmed RFID 4.0 labelling device, adaptable to small 1cm x 2cm glass vials (about 10,000,000 products annually), at a cost of less than $0.15 per label, with a fixed dual-antenna RFID reader for detecting inventory entries and rejects at a cost of less than $5,000 per reader. This system, which makes it possible to control and ensure the individual traceability of vaccine vials, from manufacture to distribution, will also have to integrate the data collected into the company's proprietary software platform. To do this, Pfizer Canada is seeking C2T3's expertise in wireless telecommunications and RFID to determine possible solutions for the development of this innovative device. For Pfizer Canada, this project is an important vehicle for innovation to develop the company's best practices in accordance with FDA, Health Canada and Industry 4.0 standards for this business line.